Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Albemarle (GB:0HC7)
LSE:0HC7
Holding GB:0HC7?
Track your performance easily
0HC7 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$71.91 - $177.66
Previous Close$99.89
Volume8.43K
Average Volume (3M)8.64K
Market Cap
$11.08B
Enterprise Value$13.04B
Total Cash (Recent Filing)$1.83B
Total Debt (Recent Filing)$3.52B
Price to Earnings (P/E)―
Beta1.71
Next Earnings
Nov 06, 2024EPS Estimate
-$0.26Last Dividend Ex-Date
Sep 13, 2024Dividend Yield1.7%
Share Statistics
EPS (TTM)-4.73
Shares Outstanding117,533,235
10 Day Avg. Volume11,385
30 Day Avg. Volume8,642
Standard Deviation0.15
R-Squared0.21
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)1.23
Price to Sales (P/S)1.49
Price to Cash Flow (P/CF)7.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.75
Enterprise Value/Gross Profit10.99
Enterprise Value/Ebitda-39.18
Forecast
1Y Price Target
$108.00Price Target Upside8.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering21
Albemarle News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceEBITDA beat by 39%
Growth ProspectsAlbemarle has multiple underdeveloped projects which are scheduled to commence within the next few years
Lithium MarketBeneficiary of growing EV popularity
Bears Say
Financial Performance3Q23 net income dropped 66% y-o-y to US$302m; below expectations.
Market ConditionsChemical and spodumene prices have eroded, threatening to put good mines into negative profitability territory.
Operational AdjustmentsALB announced that it will halt expansion plans at its Kemerton refining facility in Australia.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.21% Insiders
27.12% Mutual Funds
0.05% Other Institutional Investors
43.38% Public Companies and
Individual Investors
0HC7 FAQ
What was Albemarle’s price range in the past 12 months?
Albemarle lowest share price was $71.91 and its highest was $177.66 in the past 12 months.
What is Albemarle’s market cap?
Currently, no data Available
When is Albemarle’s upcoming earnings report date?
Albemarle’s upcoming earnings report date is Nov 06, 2024 which is in 31 days.
How were Albemarle’s earnings last quarter?
Albemarle released its earnings results on Jul 31, 2024. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.427 by -$0.387.
Is Albemarle overvalued?
According to Wall Street analysts Albemarle’s price is currently Undervalued.
Does Albemarle pay dividends?
Albemarle pays a Quarterly dividend of $0.41 which represents an annual dividend yield of 1.7%. See more information on Albemarle dividends here
What is Albemarle’s EPS estimate?
Albemarle’s EPS estimate is -$0.26.
How many shares outstanding does Albemarle have?
Albemarle has 117,533,230 shares outstanding.
What happened to Albemarle’s price movement after its last earnings report?
Albemarle reported an EPS of $0.04 in its last earnings report, missing expectations of $0.427. Following the earnings report the stock price went down -0.118%.
Which hedge fund is a major shareholder of Albemarle?
Among the largest hedge funds holding Albemarle’s share is PRIMECAP Management Co. It holds Albemarle’s shares valued at 364M.
---
Albemarle Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$108.00 (8.12% Upside)
$108.00 (8.12% Upside)
Blogger Sentiment
Bullish
GB:0HC7 Sentiment 78%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.61%
12-Months-Change
Fundamentals
Return on Equity
-4.76%
Trailing 12-Months
Asset Growth
-3.77%
Trailing 12-Months
Company Description
Albemarle
Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.
---
0HC7 Company Deck
---
0HC7 Earnings Call
Q2 2024
0:00 / 0:00
---
0HC7 Net sales Breakdown
73.61% Energy Storage
15.41% Specialties
10.98% Ketjen
---
0HC7 Stock 12 Month Forecast
Average Price Target
$108.00
▲(8.12% Upside)
Technical Analysis
Best Analysts Covering 0HC7
1 Year
1 Year Success Rate
17/37 ratings generated profit
1 Year Average Return
+16.58%
assigned a buy rating 2 months ago
Copying Colin Rusch's trades and holding each position for 1 Year would result in 45.95% of your transactions generating a profit, with an average return of +16.58% per trade.
---